Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.69 (
botulinum neurotoxin
)
1,901
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recently,
botulinum neurotoxin
type A (BoNT-A) application in the lower urinary tract has been extended to prostate disorders and we would like to review the literature on the mechanisms of action and clinical efficacy of
BoNT
-A treatment in the prostate. The information was gathered from MEDLINE, abstracts from recent urological meetings and from personal experience.
BoNT
has demonstrated promising preliminary results for male
prostatic disease
and translational research suggests a novel mechanism of action of
BoNT
in the prostate. It is important to remember that the application of
BoNT
in the prostate is not approved by the regulatory agencies and caution should be applied until larger randomised clinical studies are completed.
...
PMID:Botulinum-A toxin: an exciting new treatment option for prostatic disease. 1716 9
